Safety Study of Dacarbazine and Bortezomib in Melanoma and Soft Tissue Sarcoma
Clinical trial NCT00580320 · COMPLETED
Trial details
- NCT number
- NCT00580320
- Sponsor
- Virginia Commonwealth University
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2004-09-01
- Primary completion
- 2009-10-01
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.